Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

Well I'm not buying a single share of this garbage

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30067
Posted On: 07/13/2016 12:47:31 PM
Posted By: All Aboard
Quote:
Well I'm not buying a single share of this garbage until the books are cleaned off and audited



You act like their books are not audited. Marcum LLP audits them annually. The last audited statements were filed less than 2 months ago.

Quote:
The Fed will not fund an insolvent OTCBB with unaudited books - it simply won't happen no matter how Gerald espouses that ESS is too important for US military to forgo treating military burn victims.



Again, their books are audited. And the DoD (not the Fed) funded an insolvent OTCBB with $18M. Regenicin.

http://www.proactiveinvestors.com/companies/n...10250.html

Quote:
Eltoprazine is stalled, had lousy Ph. 2 test results



Lousy? No Eltoprazine demonstrated significant beneficial anti-dyskinesia effect at 5 and 7.5 mg doses, with no reduction of levodopa efficacy. Eltoprazine was well tolerated at all dose levels, with no major adverse effects reported. And the results supported advancing eltoprazine into Phase 2b chronic dosing, clinical studies, as a treatment for patients with Parkinson's disease levodopa -induced dyskinesia.

All published in Brain. http://www.evaluategroup.com/Universal/View.a...;id=558681

Quote:
look what happened to AMBS by climbing in bed with Robert Farrell who acted as a plant for Magna.



You sound like a crazy person. Farrell was duped by Discover Growth Fund, not Magna. Magna came in and took out Discover as a better alternative. Farrell was a Magna plant? Insane.

Quote:
So why would anyone of sane mind want to purchase more shares? Inquiring minds need to know.



No one is telling you to buy more shares. In fact, everyone is telling you to sell and get off this message board.








(12)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us